• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

白塞病患者中针对主要组织相容性复合体I类链相关基因A的自身反应性CD8 + 细胞毒性T淋巴细胞

Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease.

作者信息

Yasuoka Hidekata, Okazaki Yuka, Kawakami Yutaka, Hirakata Michito, Inoko Hidetoshi, Ikeda Yasuo, Kuwana Masataka

机构信息

Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan.

出版信息

Arthritis Rheum. 2004 Nov;50(11):3658-62. doi: 10.1002/art.20597.

DOI:10.1002/art.20597
PMID:15529349
Abstract

OBJECTIVE

To detect and characterize the autoreactive CD8+ T cells to major histocompatibility complex class I chain-related gene A (MICA), a stress-inducible antigen preferentially expressed on the epithelium and endothelium, in patients with Behcet's disease (BD).

METHODS

A candidate for the antigenic MICA peptide was selected based on its predicted binding affinity for HLA-B51 and proteasomal cleavage sites. Peripheral blood T cells from 14 patients with BD and 15 healthy controls were repeatedly stimulated with the MICA peptide, and the specific T cell response was measured by peptide-induced interferon-gamma. Cytotoxic T lymphocyte activity was examined by chromium-51 release from an HLA-B51-transfected B cell line in the presence of the MICA peptide.

RESULTS

A 9-mer peptide AAAAAIFVI (termed MICA transmembrane [MICA-TM]) was selected as a candidate for the antigenic peptide presented by HLA-B51. A specific T cell response to MICA-TM was detected in 4 patients with BD (29%) but in none of the 15 healthy donors. All 4 responders had HLA-B51 and active disease, and the specific T cell response was lost after the BD-related symptoms disappeared. The MICA-induced T cell response was specifically inhibited by anti-HLA class I antibody or by CD8+ cell depletion. MICA-reactive T cells recognized an HLA-B51-transfected B cell line pulsed with MICA-TM or a B cell line transfected with both HLA-B51 and MICA in the absence of exogenous peptides. Finally, MICA-stimulated T cell lines lysed the HLA-B51-expressing B cell line in the presence of MICA-TM.

CONCLUSION

HLA-B51-restricted cytotoxic T lymphocytes autoreactive to MICA may be involved in the pathogenesis of BD.

摘要

目的

检测和鉴定白塞病(BD)患者中针对主要组织相容性复合体I类链相关基因A(MICA)的自身反应性CD8 + T细胞。MICA是一种应激诱导抗原,优先表达于上皮和内皮细胞。

方法

根据预测的与HLA - B51的结合亲和力和蛋白酶体切割位点,选择抗原性MICA肽的候选物。用MICA肽反复刺激14例BD患者和15例健康对照的外周血T细胞,并通过肽诱导的干扰素-γ测量特异性T细胞反应。在存在MICA肽的情况下,通过从HLA - B51转染的B细胞系中释放51铬来检测细胞毒性T淋巴细胞活性。

结果

选择9聚体肽AAAAAIFVI(称为MICA跨膜区[MICA - TM])作为由HLA - B51呈递的抗原肽的候选物。在4例BD患者(29%)中检测到对MICA - TM的特异性T细胞反应,但在15例健康供体中均未检测到。所有4例反应者均具有HLA - B51且患有活动性疾病,并且在BD相关症状消失后特异性T细胞反应消失。MICA诱导的T细胞反应被抗HLA I类抗体或CD8 +细胞耗竭特异性抑制。MICA反应性T细胞识别用MICA - TM脉冲处理的HLA - B51转染的B细胞系或在没有外源性肽的情况下同时转染HLA - B51和MICA的B细胞系。最后,MICA刺激的T细胞系在存在MICA - TM的情况下裂解表达HLA - B51的B细胞系。

结论

对MICA具有自身反应性的HLA - B51限制性细胞毒性T淋巴细胞可能参与BD的发病机制。

相似文献

1
Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease.白塞病患者中针对主要组织相容性复合体I类链相关基因A的自身反应性CD8 + 细胞毒性T淋巴细胞
Arthritis Rheum. 2004 Nov;50(11):3658-62. doi: 10.1002/art.20597.
2
Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease.意大利白塞病患者中MICA等位基因与HLA - B51的关联
J Rheumatol. 2001 Aug;28(8):1867-70.
3
Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease.CD94/NKG2A、CD94/NKG2C及其配体HLA - E基因多态性与白塞病的关联
Tissue Antigens. 2007 Oct;70(4):307-13. doi: 10.1111/j.1399-0039.2007.00907.x.
4
Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease.白塞病患者外周血γδ+ T细胞和自然杀伤细胞增多。
J Rheumatol. 1992 Apr;19(4):588-92.
5
Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece.希腊MICA基因和HLA - B*5101与白塞病的关联
Invest Ophthalmol Vis Sci. 1999 Aug;40(9):1921-6.
6
Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease.日本白塞病患者中MICA与HLA - B等位基因的关联分析。
Arthritis Rheum. 1999 Sep;42(9):1961-6. doi: 10.1002/1529-0131(199909)42:9<1961::AID-ANR23>3.0.CO;2-7.
7
Phenotype markers and cytokine intracellular production by CD8+ gammadelta T lymphocytes do not support a regulatory T profile in Behçet's disease patients and healthy controls.CD8 + γδ T淋巴细胞的表型标志物和细胞因子细胞内产生情况不支持白塞病患者和健康对照中存在调节性T细胞谱。
Immunol Lett. 2010 Apr 8;129(2):57-63. doi: 10.1016/j.imlet.2010.02.005. Epub 2010 Feb 16.
8
The HLA-B*5101 molecule-binding capacity to antigens used in animal models of Behçet's disease: a bioinformatics study.白塞病动物模型中使用的抗原与HLA - B*5101分子的结合能力:一项生物信息学研究
Isr Med Assoc J. 2012 Jul;14(7):424-8.
9
[Behçet's disease and class II and III antigens of the major histocompatibility complex].[白塞病与主要组织相容性复合体的II类和III类抗原]
Rev Rhum Mal Osteoartic. 1990 Jan;57(1):59-61.
10
Telomerase (hTERT 611-626) serves as a tumor antigen in B-cell chronic lymphocytic leukemia and generates spontaneously antileukemic, cytotoxic T cells.端粒酶(hTERT 611 - 626)在B细胞慢性淋巴细胞白血病中作为肿瘤抗原,并自发产生抗白血病的细胞毒性T细胞。
Exp Hematol. 2007 Feb;35(2):297-304. doi: 10.1016/j.exphem.2006.10.006.

引用本文的文献

1
Behçet's Disease: A Comprehensive Review on the Role of , Antigen Presentation, and Inflammatory Cascade.贝赫切特病: 对 、抗原呈递和炎症级联作用的全面综述。
Int J Mol Sci. 2023 Nov 16;24(22):16382. doi: 10.3390/ijms242216382.
2
EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders.EULAR 研究小组关于“MHC-I 病”:在学科和边界内识别疾病普遍存在的机制。
Ann Rheum Dis. 2023 Jul;82(7):887-896. doi: 10.1136/ard-2022-222852. Epub 2023 Mar 27.
3
HLA association with biliary atresia in north India.
印度北部HLA与胆道闭锁的关联。
Indian J Med Res. 2022 Sep;156(3):554-559. doi: 10.4103/ijmr.ijmr_1145_21.
4
Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.白塞病风险变体 HLA-B51/ERAP1-Hap10 改变人类 CD8 T 细胞免疫。
Ann Rheum Dis. 2022 Nov;81(11):1603-1611. doi: 10.1136/ard-2022-222277. Epub 2022 Aug 3.
5
The Impact of the 'Mis-Peptidome' on HLA Class I-Mediated Diseases: Contribution of ERAP1 and ERAP2 and Effects on the Immune Response.“错构肽组”对 HLA Ⅰ类分子相关疾病的影响:ERAP1 和 ERAP2 的作用及其对免疫反应的影响。
Int J Mol Sci. 2020 Dec 17;21(24):9608. doi: 10.3390/ijms21249608.
6
Redundancy and Complementarity between ERAP1 and ERAP2 Revealed by their Effects on the Behcet's Disease-associated HLA-B*51 Peptidome.内质网氨肽酶 1(ERAP1)和 ERAP2 对 Behcet 病相关 HLA-B*51 肽组的影响揭示了它们之间的冗余性和互补性。
Mol Cell Proteomics. 2019 Aug;18(8):1491-1510. doi: 10.1074/mcp.RA119.001515. Epub 2019 May 15.
7
Clinical and Genetic Aspects of Behçet's Disease in Japan.日本白塞病的临床与遗传学方面
Intern Med. 2019 May 1;58(9):1199-1207. doi: 10.2169/internalmedicine.2035-18. Epub 2019 Jan 10.
8
Is Behçet's disease a 'class 1-opathy'? The role of HLA-B*51 in the pathogenesis of Behçet's disease.白塞病是一种“一类疾病”吗?HLA - B*51在白塞病发病机制中的作用。
Clin Exp Immunol. 2018 Jan;191(1):11-18. doi: 10.1111/cei.13049. Epub 2017 Oct 6.
9
The Behçet's disease-associated variant of the aminopeptidase ERAP1 shapes a low-affinity HLA-B*51 peptidome by differential subpeptidome processing.与白塞病相关的氨肽酶ERAP1变体通过差异亚肽组加工形成低亲和力的HLA - B*51肽组。
J Biol Chem. 2017 Jun 9;292(23):9680-9689. doi: 10.1074/jbc.M117.789180. Epub 2017 Apr 26.
10
Associations of MICA Polymorphisms with Inflammatory Rheumatic Diseases.MICA基因多态性与炎性风湿性疾病的关联。
Open Rheumatol J. 2015 Nov 24;9:94-100. doi: 10.2174/1874312901409010094. eCollection 2015.